Epidermal growth factor receptor transactivation is regulated by glucose in vascular smooth muscle cells.
about
Protein N-glycosylation in oral cancer: dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signalingExpression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complicationsGas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cellsDiabetes and microvascular pathophysiology: role of epidermal growth factor receptor tyrosine kinase.Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular SystemThrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor beta type I receptor.Glucosamine inhibits epidermal growth factor-induced proliferation and cell-cycle progression in retinal pigment epithelial cellsCaveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin IILigand-dependent differences in estrogen receptor beta-interacting proteins identified in lung adenocarcinoma cells corresponds to estrogenic responses.Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways.Role of epidermal growth factor receptor in acute and chronic kidney injury.Combined Effects of PPAR γ Agonists and Epidermal Growth Factor Receptor Inhibitors in Human Proximal Tubule Cells.Reduction of the ST6 β-galactosamide α-2,6-sialyltransferase 1 (ST6GAL1)-catalyzed sialylation of nectin-like molecule 2/cell adhesion molecule 1 and enhancement of ErbB2/ErbB3 signaling by microRNA-199a.ADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice.N-Glycans in cancer progression.Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice.A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus.Metabolism, cell surface organization, and disease.Renal epidermal growth factor receptor: its role in sodium and water homeostasis in diabetic nephropathy.Simvastatin inhibits glucose-stimulated vascular smooth muscle cell migration involving increased expression of RhoB and a block of Ras/Akt signal.Hydrogen peroxide activates the Gas6-Axl pathway in vascular smooth muscle cells.Angiotensin II-induced Akt activation is mediated by metabolites of arachidonic acid generated by CaMKII-stimulated Ca2(+)-dependent phospholipase A2.EGFR-PLCgamma1 signaling mediates high glucose-induced PKCbeta1-Akt activation and collagen I upregulation in mesangial cells.Diabetes-induced renal vascular dysfunction is normalized by inhibition of epidermal growth factor receptor tyrosine kinase.11β-HSD1 inhibition ameliorates diabetes-induced cardiomyocyte hypertrophy and cardiac fibrosis through modulation of EGFR activity.Essential role for EGFR tyrosine kinase and ER stress in myocardial infarction in type 2 diabetes.
P2860
Q26861795-ACE30DE5-BA76-4959-8315-5A118AB2BA7FQ28472170-3C0C8B08-1E75-41A9-BD25-0FCB95F83169Q28576589-FC9B2AB8-A185-42D9-9A1A-E63587411141Q33662459-82A06BC7-085D-4BD1-86D3-449E9FC869D9Q33814199-DC8A604E-2729-4415-B4B4-527ED918BA6DQ34094307-5C044FE5-4440-45D3-9F30-9DDD01975B90Q34396880-629427CD-72E4-45EB-8907-77C278E1299BQ34561198-104D336A-7BBA-421C-A73C-BFC8BC232785Q35338975-3F2ED734-F20B-432D-8AEB-7C21D23016F6Q35609910-C958F7D7-F48D-493B-9AA7-9625FFE07526Q36224457-6F5A0F11-5A0B-495C-9B6A-43782D396135Q36682692-2A3A787D-BF8F-4F5E-90B0-2F87CAA1499AQ36796821-97F886E6-7FF0-4A5D-BC05-EBD1A3CE4E69Q37093660-96EF10B2-A561-4170-9E29-505651A191C3Q37243167-542A4811-9FCC-401E-B945-3A64E30F04B3Q37379205-AABB82CF-D5F5-422E-9986-47EE9E7D6870Q37560339-B0EEA56C-A87A-4C28-AC39-D4CBC2046ED5Q37671886-ACA8ABCA-B74E-485D-A76F-41686F77F6CCQ37820693-92687A01-4DB6-47AF-B9D6-3C93FE4B8DF0Q39644202-CC6F58FF-687F-4759-B06A-FF5E78EE9511Q44881270-9FE71336-A9BF-46AB-B056-B506B5F089E7Q45214791-B3C86187-0005-4828-8C61-08CD8C3C79E9Q45928369-6DCE48F6-FC61-4459-8FB5-EF1E645D96C1Q46508745-FE0E016B-7814-48BD-8A25-582C2285BE1FQ47094783-43639D6D-0D9B-4330-BD05-6F7F8911CC75Q49484658-3B6F1633-9C26-4AB9-BFF7-1D69A5F4237E
P2860
Epidermal growth factor receptor transactivation is regulated by glucose in vascular smooth muscle cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Epidermal growth factor recept ...... vascular smooth muscle cells.
@en
Epidermal growth factor recept ...... vascular smooth muscle cells.
@nl
type
label
Epidermal growth factor recept ...... vascular smooth muscle cells.
@en
Epidermal growth factor recept ...... vascular smooth muscle cells.
@nl
prefLabel
Epidermal growth factor recept ...... vascular smooth muscle cells.
@en
Epidermal growth factor recept ...... vascular smooth muscle cells.
@nl
P2860
P356
P1476
Epidermal growth factor recept ...... vascular smooth muscle cells.
@en
P2093
Atsushi Konishi
P2860
P304
35049-35056
P356
10.1074/JBC.M304913200
P407
P577
2003-06-26T00:00:00Z